The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Microglia and Neuroinflammation: What Place for P2RY12?
Open accessAbstract
Microglia are immune brain cells involved in neuroinflammation. They express a lot of proteins on their surface such as receptors that can be activated by mediators released in the microglial environment. Among these receptors, purinergic receptor expression could be modified depending on the activation status of microglia. In this review, we focus on P2Y receptors and more specifically on P2RY12 that is involved in microglial motility and migration, the first step of neuroinflammation process. We describe the purinergic receptor families, P2RY12 structure, expression and physiological functions. The pharmacological and genetic tools for studying this receptor are detailed thereafter. Last but not least, we report the contribution of microglial P2RY12 to neuroinflammation in acute and chronic brain pathologies in order to better understand P2RY12 microglial role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Purinergic receptors and microglial activation states (modified from [37]). In response to ATP release from damaged cells, P2RY12 stimulation triggers the extension of microglial processes towards the site of injury, in cooperation with the adenosine receptor (AR) A3. Both these receptors are upregulated during this step. Then, P2RY12 downregulation and ARA2A upregulation induce the retractation of these processes. Microglial migratory activity also depends on the interaction between P2RY12 and P2RX4. After total retraction of processes, microglia adopt an amoeboid morphology, and exert phagocytosis, pinocytosis or secretory activity depending on the receptor involved. ↑: upregulation or increased activation; ↓: downregulation or reduced activation.](/paper-figures/58f74a546389462b86cca0e2e02f2be3/microglia-and-neuroinflammation-what-place-for-p2ry12-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“whereas M7 shows high expression of activation marker Tyrobp. 36 , 37 , 38”
From Loss of Inpp5d has disease‐relevant and sex‐specific effects on glial transcriptomes (2024) · cites this paper as [37]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Burnstock, G. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06930-3 · Cited by 1,852
Neuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640
A polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542
Microglia in physiology and disease
Wolf, S. A., Boddeke, H. W. G. M., & Kettenmann, H. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034406 · Cited by 1,426
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
Colton, C. A. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9164-4 · Cited by 916
Inflammasomes in neuroinflammatory and neurodegenerative diseases
Voet, S., Srinivasan, S., Lamkanfi, M., & van Loo, G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810248 · Cited by 761
Cited by
Sorted by citations
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Guan, F., Wang, R., Yi, Z., Luo, P., Liu, W., Xie, Y., Liu, Z., Xia, Z., Zhang, H., & Cheng, Q. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02124-y · Cited by 371
Beyond Activation: Characterizing Microglial Functional Phenotypes
Lier, J., Streit, W. J., & Bechmann, I. (2021) · Cells · doi:10.3390/cells10092236 · Cited by 274
“As shown in studies using single-cell RNA sequencing in Alzheimer’s disease and other neurodegenerative conditions, P2RY12 is one of the proteins marking the transition from homeostatic microglia to disease-associated microglia by the downregulation of gene expression [55,61].”
BackgroundResultHuman Microglia Show Unique Transcriptional Changes in Alzheimer's Disease
Prater, K. E., Green, K. J., Mamde, S., Sun, W., Cochoit, A., Smith, C. L., Chiou, K. L., Heath, L., Rose, S. E., Wiley, J., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00424-y · Cited by 164
Retinal microglia: Functions and diseases
Fan, W., Huang, W., Chen, J., Li, N., Mao, L., & Hou, S. (2022) · Immunology · doi:10.1111/imm.13479 · Cited by 139
Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
Martirosyan, A., Ansari, R. A., Pestana, F., Hebestreit, K., Gasparyan, H. A., Aleksanyan, R., Hnatova, S., Poovathingal, S. K., Marneffe, C., Thal, D. R., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00699-0 · Cited by 145
Miao, Y., Zhao, G., Cheng, S., Wang, Z., & Yang, X.-L. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2023.101169 · Cited by 126
Microglial morphometric analysis: so many options, so little consistency
Reddaway, J., Richardson, P., Bevan, R. J., Stoneman, J., & Palombo, M. (2023) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2023.1211188 · Cited by 131
Quantifying microglial morphology: an insight into function
Green, T. R. F., & Rowe, R. K. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae023 · Cited by 119
Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases
Javanmehr, N., Saleki, K., Alijanizadeh, P., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02637-1 · Cited by 106
Han, Q.-Q., & Le, W. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01023-y · Cited by 106
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders
Kempuraj, D., Dourvetakis, K. D., Cohen, J., Valladares, D. S., Joshi, R. S., Kothuru, S. P., Anderson, T., Chinnappan, B., Cheema, A. K., Klimas, N. G., et al. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1491952 · Cited by 78
Towards PET imaging of the dynamic phenotypes of microglia
Beaino, W., Janssen, B., Vugts, D. J., de Vries, H. E., & Windhorst, A. D. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13649 · Cited by 63
STAMarker: determining spatial domain-specific variable genes with saliency maps in deep learning
Zhang, C., Dong, K., Aihara, K., Chen, L., & Zhang, S. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad801 · Cited by 54
Brain region- and sex-specific transcriptional profiles of microglia
Barko, K., Shelton, M. A., Xue, X., Afriyie-Agyemang, Y., Puig, S., Freyberg, Z., Tseng, G. C., Logan, R. W., & Seney, M. L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.945548 · Cited by 56
Glioblastoma microenvironment—from biology to therapyPreprint
Read, R. D., Tapp, Z. M., Rajappa, P., & Hambardzumyan, D. (2024) · Genes & Development · doi:10.1101/gad.351427.123 · Cited by 51
Entsie, P., Kang, Y., Amoafo, E. B., Schöneberg, T., & Liverani, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076709 · Cited by 45
Zhang, P., Gao, C., Guo, Q., Yang, D., Zhang, G., Lü, H., Zhang, L., Zhang, G., & Li, D. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03113-8 · Cited by 44
Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing
Marques, C. F., Marques, M. M., & Justino, G. C. (2022) · Pharmaceuticals · doi:10.3390/ph15091039 · Cited by 47
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
Lee, E., & Chang, Y. (2025) · Cells · doi:10.3390/cells14030168 · Cited by 39
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases
Beura, S. K., Dhapola, R., Panigrahi, A. R., Yadav, P., Kumar, R., HariKrishnaReddy, D., & Singh, S. K. (2023) · Medicinal Research Reviews · doi:10.1002/med.21965 · Cited by 37
Shen, Y., Liu, F., & Zhang, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117235 · Cited by 36
Engel, T., Smith, J., & Alves, M. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s287740 · Cited by 36
You, S., Su, X., Ying, J., Li, S., Qu, Y., & Mu, D. (2022) · Biomolecules · doi:10.3390/biom12081158 · Cited by 35
Lee, J., Kim, S. W., & Kim, K.-T. (2022) · Cells · doi:10.3390/cells11121902 · Cited by 34
Zhao, W., Liu, Z., Wu, J., Liu, A., & Yan, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01343 · Cited by 37
Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer's Disease Continuum
Bieger, A., Rocha, A., Bellaver, B., Machado, L. S., Ros, L. U. D., Borelli, W. V., Therriault, J., Macedo, A. C., Pascoal, T. A., Gauthier, S. G., et al. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.54 · Cited by 29
Genetic insights into immune mechanisms of Alzheimer’s and Parkinson’s disease
Nott, A., & Holtman, I. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1168539 · Cited by 33
Évora, A., Garcia, G., Rubi, A., Vitis, E. D., Matos, A. T., Vaz, A. R., Gervaso, F., Gigli, G., Polini, A., & Brites, D. M. T. O. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1474012 · Cited by 31
Glial Cell Dynamics in Neuroinflammation: Mechanisms, Interactions, and Therapeutic Implications
García‐Domínguez, M. (2026) · Biomedicines · doi:10.3390/biomedicines14010115 · Cited by 32
Sun, J., Chen, F., She, L., Zeng, Y., Tang, H., Ye, B., Zheng, W., Xiong, L., Li, L., Li, L., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.11.020 · Cited by 24
Škandík, M., Frieß, L., Vázquez-Cabrera, G., Keane, L., Grabert, K., Santos, M. C. D. L., Posada-Pérez, M., Balevičiūtė, A., Cheray, M., & Joseph, B. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02295-1 · Cited by 26
Trehalose Treatment in Zebrafish Model of Lafora Disease
Vecchia, S. D., Ogi, A., Licitra, R., Abramo, F., Nardi, G., Mero, S., Landi, S., Battini, R., Sicca, F., Ratto, G. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126874 · Cited by 23
McGeachan, R. I., Meftah, S., Taylor, L. W., Catterson, J. H., Negro, D., Bonthron, C., Holt, K., Tulloch, J., Rose, J. L., Gobbo, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58879-z · Cited by 23
You, Y., Chen, Z., & Hu, W. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108606 · Cited by 25
Neuroinflammation and iron metabolism after intracerebral hemorrhage: a glial cell perspective
Ju, J.-J., & Hang, L. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2024.1510039 · Cited by 22
Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
Onyango, I. G., Bennett, J. P., & Stokin, G. B. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211208125855 · Cited by 22
Asveda, T., Talwar, P., & Ravanan, P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121920 · Cited by 23
Hanin, A., Zhang, L., Huttner, A. J., Plu, I., Mathon, B., Bielle, F., Navarro, V., Hirsch, L. J., & Hafler, D. A. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200259 · Cited by 22
Molecular Mechanisms of Chronic Pain and Therapeutic Interventions
Li, Z., Li, X., Liu, J., Sun, R., Ye, Y., Xiang, H., Luo, F., Li, S., & Luo, A. (2025) · MedComm · doi:10.1002/mco2.70325 · Cited by 31
Short-Term Sleep Fragmentation Dysregulates Autophagy in a Brain Region-Specific Manner
Cheng, Y., Kim, W., Wellman, L. L., Sanford, L. D., & Guo, M. (2021) · Life · doi:10.3390/life11101098 · Cited by 22
Güvenek, A., Parikshak, N., Zamolodchikov, D., Gelfman, S., Moscati, A., Dobbyn, L., Stahl, E. A., Shuldiner, A. R., & Coppola, G. (2024) · Communications Biology · doi:10.1038/s42003-024-06684-7 · Cited by 23
Tsourmas, K. I., Butler, C. A., Kwang, N. E., Sloane, Z. R., Dykman, K. J. G., Maloof, G. O., Choudhury, B., Paulchakrabarti, M., Prekopa, C. A., Tabaie, E. Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63237-0 · Cited by 25
Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
Schreiner, T. G., & Popescu, B. O. (2022) · Life · doi:10.3390/life12030330 · Cited by 23
Chen, D., Jiang, H., Sun, L., Nurzat, Y., Qin, H., Zhao, Z., Liu, D., Zheng, S., Wang, L., Fu, Y., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03730-2 · Cited by 19
Microbiota mitochondria disorders as hubs for early age-related macular degeneration
Fehér, J., Élő, Á., István, L., Nagy, Z. Z., Radak, Z. O., Scuderi, G., Artico, M., & Kovács, I. (2022) · GeroScience · doi:10.1007/s11357-022-00620-5 · Cited by 20
Bobotis, B. C., Halvorson, T., Carrier, M., & Tremblay, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1317125 · Cited by 22
Bertin, É., Martínez, A., Fayoux, A., Carvalho, K., Carracedo, S., Fernagut, P., Koch‐Nolte, F., Blum, D. L., Bertrand, S. S., & Boué‐Grabot, É. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04461-5 · Cited by 19
Zhang, Z., Niu, K., Huang, T., Guo, J., Xarbat, G., Gong, X., Gao, Y., Liu, F., Shan, C., Su, W., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-024-00846-4 · Cited by 21
Geraci, J., Bhargava, R., Qorri, B., Leonchyk, P., Cook, D. J., Cook, M., Sie, F., & Pani, L. (2024) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2023.1199736 · Cited by 19
Sex-dependent effects of a high-fat diet on the hypothalamic response in mice
Dreux, V., Lefebvre, C., Breemeersch, C.-E., Salaün, C., Bôle‐Feysot, C., Guérin, C., Déchelotte, P., Goichon, A., Coëffier, M., & Langlois, L. D. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00699-3 · Cited by 18
Miao, G., Fortier, T. M., Liu, H., Schafer, D. P., Fitzgerald, K. A., Mao, J., & Baehrecke, E. H. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01602-9 · Cited by 18
Moya-Gómez, A., Font, L. P., Burlacu, A., Alpizar, Y. A., Cardonne, M. M., Brône, B., & Bronckaers, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311117 · Cited by 18
Advanced brain imaging for the diagnosis of Alzheimer disease
Wang, Y.-T. T., Rosa‐Neto, P., & Gauthier, S. G. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001198 · Cited by 16
Microglial purinergic signaling in Alzheimer’s disease
Mei, S.-Y., Zhang, N., Wang, M., Lv, P.-R., & Liu, Q. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10029-8 · Cited by 18
MicroRNAs Modulating Neuroinflammation in Parkinson's disease
Saadh, M. J., Muhammad, F. A., Singh, A., Mustafa, M. A., Zuhairi, R. A. H. A., Ghildiyal, P., Hashim, G. M., Alsaikhan, F., Khalilollah, S., & Akhavan‐Sigari, R. (2024) · Inflammation · doi:10.1007/s10753-024-02125-z · Cited by 16
Ye, T., Fan, Y., Zeng, X., Wang, X., & Xiao, H. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002257 · Cited by 15
Naffaa, M. M. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100676 · Cited by 20
Bathe, T., Hery, G. P., Villareal, J. A. B., Phillips, J. L., Cohen, E. M., Sharma, R. V., Tsering, W., & Prokop, S. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01770-7 · Cited by 15
Nheu, D., Ellen, O., Ye, S., Öztürk, E., Pagnin, M., Kertadjaja, S., Theotokis, P., Grigoriadis, N., McLean, C., & Petratos, S. (2022) · Cells · doi:10.3390/cells11233768 · Cited by 16
P2Y12 receptor gene polymorphisms are associated with epilepsy
Wang, Q., Shi, N.-R., Lv, P., Liu, J., Zhang, J., Deng, B.-L., Zuo, Y.-Q., Yang, J., Wang, X., Chen, X., et al. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09848-4 · Cited by 15
Wang, P., Mi, Y., Yu, H. N., Teng, X., Jin, S., Xiao, L., Xue, H., Tian, D., Guo, Q., & Wu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116549 · Cited by 15
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?
Bassani, D., Pavan, M., Federico, S., Spalluto, G., Sturlese, M., & Moro, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094504 · Cited by 13
Xu, N., Liu, Z., Yang, Q., Bian, P., Li, M., & Zhao, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.906447 · Cited by 13
Huang, T., Wu, J., Mu, J., & Gao, J. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00605 · Cited by 13
Spinal Cord Injury Management Based on Microglia-Targeting Therapies
Schreiner, T. G., Schreiner, O. D., & Ciobanu, R. C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102773 · Cited by 13
Arutyunov, A., Durán‐Laforet, V., Ai, S., Ferrari, L. L., Murphy, R., Schafer, D. P., & Klein, R. S. (2024) · Biomolecules · doi:10.3390/biom14070808 · Cited by 14
Platelets: A new therapeutic target for neurological diseases
Wei, X., & Tang, X.-Q. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102874 · Cited by 12
Inflammation in Health and Disease: New Insights and Therapeutic Avenues
Scotece, M., & Conde, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158392 · Cited by 12
Chun, B. J., Aryal, S. P., Varughese, P., Sun, B., Bruno, J., Richards, C. I., Bachstetter, A. D., & Kekenes-Huskey, P. M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2022.1037417 · Cited by 12
Zhang, W., Li, M., Wang, C., Feng, X., Hu, D.-X., Wu, L., & Hu, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114975 · Cited by 11
Microglial proliferation and astrocytic protein alterations in the human Huntington's disease cortex
Tan, A. Y. S., Tippett, L. J., Turner, C. P., Swanson, M. E. V., Park, T., Curtis, M. A., Faull, R. L. M., Dragunow, M., & Singh‐Bains, M. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106554 · Cited by 13
Loss of Inpp5d has disease‐relevant and sex‐specific effects on glial transcriptomes
Dabin, L. C., Kersey, H., Kim, B., Acri, D. J., Sharify, D., Lee‐Gosselin, A., Lasagna‐Reeves, C. A., Oblak, A. L., Lamb, B. T., & Kim, J. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13901 · Cited by 10
Metabolic and inflammatory roles of glial cells in neurodegenerative and cerebrovascular diseases
OGUNLEYE, F. A., Zhou, Y., Yan, L., Abhulimen, P. O., Xu, Y., Lai, M. K. P., Okunowo, W. O., Sethi, G., Fang, C., & Ma, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103120 · Cited by 11
Roles of biomaterials in modulating the innate immune response in ocular therapy
Rafiei, M., Chung, J. T., & Chau, Y. (2023) · Frontiers in Drug Delivery · doi:10.3389/fddev.2023.1077253 · Cited by 10
Brezáni, V., Joshi, R., Ortega‐Ribera, M., Nagesh, P. T., Brezáni, V., Zivny, A., Kurt‐Jones, E. A., Golenbock, D. T., & Szabó, G. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03501-8 · Cited by 12
Diagnostic and therapeutic value of P2Y12R in epilepsy
Chen, X., Wang, Q., Yang, J., Zhang, L., Liu, T., Liu, J., Deng, B.-L., & Liu, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1179028 · Cited by 10
Goleij, P., Amini, A., Tabari, M. A. K., Hadipour, M., Rezaee, A., Daglia, M., Aschner, M., Sanaye, P. M., Kumar, A. P., & Khan, H. Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114399 · Cited by 9
Transcriptional Regulation of Microglial Metabolic and Activation States by P2RY12
Lopez‐Ortiz, A. O., Doceti, M., Thomas, J., Duffy, A., Coburn, M., Okojie, A. K., Lee, A., Sou, E. A., Gaultier, A., & Eyo, U. B. (2025) · Glia · doi:10.1002/glia.70078 · Cited by 12
Microglia at the scene of the crime: what their transcriptomics reveal about brain health
Arutyunov, A., & Klein, R. S. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001151 · Cited by 9
Germelli, L., Angeloni, E., Pozzo, E. D., Tremolanti, C., Felice, M. D., Giacomelli, C., Marchetti, L., Muscatello, B., Barresi, E., Taliani, S., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05544-1 · Cited by 10
Fang, K. (2024) · Ibrain · doi:10.1002/ibra.12185 · Cited by 10
Liu, L., Li, P., Wilkerson, B. A., Wu, Y., Liu, M., Jiang, W., Hamlett, E. D., Carroll, S. L., & Fan, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1648278 · Cited by 9
A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer’s disease
Becerra-Calixto, A., Banerjee, A., Fan, H., Tan, C., Lee, E., McCullough, L. D., & Lee, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03544-x · Cited by 10
Azadian, M. M., Shabestari, S. K., Rajan, A., Martinez, P. J., Macedo, N., Markarian, E., Xiang, Y., Yu, B. J., George, P. M., Fame, R. M., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02866-8 · Cited by 12
Semaglutide attenuates neuroinflammation in male mice
Rausch, D. M., Ludwig, M. Q., Bentsen, M. A., Hansen, S. N., Secher, A., Holst, D., Moreno, J., Das, V., Egerod, K. L., Bjerregaard, A.-M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74038-4 · Cited by 10
P2 Receptor Signaling in Motor Units in Muscular Dystrophy
Khairullin, A. E., Grishin, S. N., & Зиганшин, А. У. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021587 · Cited by 8
Zhang, T., Adams, C., Fejér, G., Ercolano, E., Cutajar, J., Na, J., Sahm, F., & Hanemann, C. O. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03419-2 · Cited by 8
Ganglioglioma deep transcriptomics reveals primitive neuroectoderm neural precursor-like population
Regal, J. A., García, M. E. G., Jain, V. K., Chandramohan, V., Ashley, D. M., Gregory, S. G., Thompson, E. M., Lopez, G. Y., & Reitman, Z. J. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01548-3 · Cited by 7
Wei, L., Wang, T., Luo, M., Zhang, S., Lu, M., Zhou, X., Cheng, X., Wang, H., & Xu, D. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110814 · Cited by 7
Coffee and Alzheimer's disease
Mirzaei, F., Agbaria, L., Bhatnagar, K., Sirimanne, N., A'amar, N. O., Jindal, V., Thilagendra, A. G., & Raba, F. T. (2024) · Progress in brain research · doi:10.1016/bs.pbr.2024.06.002 · Cited by 8
He, X., Yang, X., Li, G., Zhao, Y., Luo, J., Xu, J., Zheng, H., Zhang, L., & Hu, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04391-2 · Cited by 7
Chang, J., Li, Z., Yuan, H., Wang, X., Xu, J., Yang, P., & Qin, L. (2024) · Communications Biology · doi:10.1038/s42003-024-07215-0 · Cited by 7
Ferrucci, L., Basilico, B., Reverte, I., Pagani, F., Scaringi, G., Cordella, F., Cortese, B., Propris, G. D., Galeone, A., Mazzarella, L., et al. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1456974 · Cited by 7
Hisaoka‐Nakashima, K., Tokuda, S., Goto, T., Yoshii, N., Nakamura, Y., Ago, Y., & Morioka, N. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115590 · Cited by 7
The bumpy road of purinergic inhibitors to clinical application in immune-mediated diseases
Wyss, M. T., Heuer, C., & Herwerth, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.386405 · Cited by 7
Holtman, I. R., Glass, C. K., & Nott, A. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_29 · Cited by 6
Johansson, K. U. I., & Mohlin, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010871 · Cited by 6
Microglial Positron Emission Tomography Imaging In Vivo
Ottoy, J., Picker, L. D., & Kang, M. S. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_32 · Cited by 6
Stoessel, M. B., Stowell, R. D., Lowery, R. L., Le, L., Vu, A. N., Whitelaw, B. S., & Majewska, A. K. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.036 · Cited by 7
Wang, J., Song, W., Zhang, Y., Wang, J., Wang, Y., Song, J., & Zhou, Y. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04114-y · Cited by 5
Metadata
- Authors
- Gómez Morillas, A., Besson, V. C., & Lerouet, D.
- Affiliations
- UMR-S1144–Optimisation Thérapeutique en Neuropsychopharmacologie (OTeN), Faculté de Pharmacie de Paris, 4 Avenue de l’Observatoire, Université de Paris, 75006 Paris, France
- Université Paris Cité (FR)
- Corresponding author
- Lerouet, Dominique
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-02-06
- Volume
- 22
- Issue
- 4
- Pages
- 1636
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7915979
- OpenAlex
- W3126430294
- Cited by
- 214
- References
- 96
- Citations by year
- 2026: 36 · 2025: 50 · 2024: 72 · 2023: 32 · 2022: 18 · 2021: 6
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fondation des Gueules Cassées
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- microglia, neuroinflammation, P2Y12 receptor, P2Y receptors, purinergic receptors, microglial motility, microglial migration, pharmacological tools, genetic instruments
- MeSH terms
- Brain, Brain Diseases, Cell Movement, Humans, Inflammation, Lymphocyte Activation, Signal Transduction, Microglia, Receptors, Purinergic P2Y12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review